RESPONSE™
Pharmacogenomic Testing

Pharmacogenomics provides information on a patient’s genetic make-up that can be used to determine how a prescribed drug will relate with him or her. This will give the physician valuable insight into the efficacy of the drug but also potential undesired drug reactions.

Our DNA acts as a template to produce very important proteins known as enzymes. These enzymes are used to act upon certain target substances, like a drug, in order to trigger a reaction. In this case, the reaction would ideally be what allows the drug to do its intended work. A pharmacogenomics test will provide the information needed to allow the physician to prescribe the right medications and avoid those that would be both inefficient and/or could cause adverse drug interactions

By isolating and examining the regions of a patient’s DNA that code for the enzymes of interest, we can provide the following answers:

How do enzymes interact with their targets, and how does the patient’s genetic makeup affect these interactions?
How do enzymes interact with their targets, and how does the patient’s genetic makeup affect these interactions?

Enzymes modify drugs into their active and inactive metabolites. A person’s genetic makeup may seriously affect how well certain enzymes perform.

How well does the patient metabolize/utilize drugs, and what personal factors are being used to aid in drug selection?
How well does the patient metabolize/utilize drugs, and what personal factors are being used to aid in drug selection?

RESPONSE™ acts as a lifelong prescribing roadmap, steering the provider towards drugs that are metabolized efficiently and away from those that are not.

Is there a system to identify when a patient is taking a medication that is poorly suited for them?
Is there a system to identify when a patient is taking a medication that is poorly suited for them?

RESPONSE™ acts as a safeguard, protecting both physician and patient from undesirable adverse drug reactions.

How can a physician reduce drug-drug interactions when a patient is prescribed multiple medications?
How can a physician reduce drug-drug interactions when a patient is prescribed multiple medications?

RESPONSE™ flags potentially dangerous interactions between drugs and often suggests suitable alternatives.

RESPONSE™ offers

A lifelong prescribing roadmap that will steer the provider toward drugs that are metabolized efficiently and away from those that are not.

A safeguard, protecting both physician and patient from undesirable, adverse drug reactions and potentially dangers drug-drug interactions.

In cases of potential adverse drug reactions or unfavorable drug-drug interactions, RESPONSE™ often suggests suitable alternatives.

Who To Test?

Patients that experience less than optimal results from prescribed medications.

Patients with a personal or family history of adverse drug reactions in response to certain medications.

Patients taking multiple prescribed medications for multiple chronic conditions.

For more information, check out our test menu here:

FDA studies estimate that 7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%.<br><br>
FDA studies estimate that 7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%.

There are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually.<br><br>
There are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually.